DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $83,585 | +5.2% | 336,900 | +1.8% | 0.81% | +8.8% |
| Q2 2023 | $79,416 | -7.1% | 330,900 | -2.4% | 0.74% | -15.8% |
| Q1 2023 | $85,442 | -1.4% | 339,000 | +3.8% | 0.88% | -9.4% |
| Q4 2022 | $86,686 | -99.9% | 326,600 | -13.3% | 0.97% | -5.2% |
| Q3 2022 | $97,272,000 | -4.5% | 376,600 | -6.2% | 1.02% | +7.9% |
| Q2 2022 | $101,839,000 | +556.2% | 401,700 | +269.9% | 0.95% | +421.4% |
| Q2 2019 | $15,520,000 | +8.3% | 108,595 | 0.0% | 0.18% | +9.6% |
| Q1 2019 | $14,337,000 | +48.8% | 108,595 | +1.7% | 0.17% | +13.7% |
| Q4 2018 | $9,634,000 | -12.4% | 106,795 | +5.5% | 0.15% | -43.4% |
| Q3 2018 | $10,996,000 | +10.1% | 101,195 | 0.0% | 0.26% | +3.2% |
| Q2 2018 | $9,986,000 | +3.5% | 101,195 | +2.7% | 0.25% | -0.4% |
| Q1 2018 | $9,644,000 | +28.4% | 98,495 | +1.3% | 0.25% | +6.4% |
| Q4 2017 | $7,513,000 | -15.0% | 97,195 | -5.6% | 0.24% | +1.7% |
| Q3 2017 | $8,835,000 | +0.9% | 102,995 | -0.8% | 0.23% | -3.7% |
| Q2 2017 | $8,759,000 | +559.6% | 103,795 | +525.2% | 0.24% | -6.2% |
| Q1 2017 | $1,328,000 | +12.3% | 16,602 | +3.5% | 0.26% | +6.6% |
| Q4 2016 | $1,183,000 | -5.9% | 16,035 | 0.0% | 0.24% | -3.6% |
| Q3 2016 | $1,257,000 | -12.0% | 16,035 | +2.1% | 0.25% | -24.2% |
| Q2 2016 | $1,428,000 | +11.3% | 15,710 | +1.9% | 0.33% | +10.7% |
| Q1 2016 | $1,283,000 | – | 15,413 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |